120 related articles for article (PubMed ID: 7021451)
1. Clinical evaluation of bromperidol versus haloperidol in psychotic patients.
Denijs EL
Int Pharmacopsychiatry; 1980; 15(5):309-17. PubMed ID: 7021451
[TBL] [Abstract][Full Text] [Related]
2. Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients.
Malfroid M; Hens L; Roosen P; Dom R
Acta Psychiatr Belg; 1978; 78(1):147-54. PubMed ID: 347877
[TBL] [Abstract][Full Text] [Related]
3. Clinical experiences in an open and a double-blind trial.
Pöldinger W
Acta Psychiatr Belg; 1978; 78(1):96-101. PubMed ID: 347884
[TBL] [Abstract][Full Text] [Related]
4. Double-blind study with two butyrophenone derivatives: bromperidol vs. haloperidol.
Pöldinger W; Bures E; Haage H
Int Pharmacopsychiatry; 1977; 12(3):184-92. PubMed ID: 334688
[TBL] [Abstract][Full Text] [Related]
5. Use of bormperidol in psychotic outpatients.
Clarysse HJ
Acta Psychiatr Belg; 1978; 78(1):129-33. PubMed ID: 347875
[TBL] [Abstract][Full Text] [Related]
6. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
Woggon B
Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
[TBL] [Abstract][Full Text] [Related]
7. [Clinical experience with bromperidol in chronic psychoses].
Bellomo LE; Rosset N; Tellarini L; Forconesi N
Acta Psiquiatr Psicol Am Lat; 1988 Sep; 34(3):230-6. PubMed ID: 3071092
[TBL] [Abstract][Full Text] [Related]
8. Bromperidol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in psychoses.
Benfield P; Ward A; Clark BG; Jue SG
Drugs; 1988 Jun; 35(6):670-84. PubMed ID: 3048975
[TBL] [Abstract][Full Text] [Related]
9. Preliminary note on the antipsychotic efficacy of bromperidol.
Bataille M
Acta Psychiatr Belg; 1978; 78(1):173-9. PubMed ID: 347879
[TBL] [Abstract][Full Text] [Related]
10. Results of a clinical trial with bromperidol C-C 2489/21.
Weiser G
Acta Psychiatr Belg; 1978; 78(1):102-9. PubMed ID: 347873
[TBL] [Abstract][Full Text] [Related]
11. Depot bromperidol decanoate for schizophrenia.
Wong D; Adams CE; David A; Quraishi SN
Cochrane Database Syst Rev; 2004; (3):CD001719. PubMed ID: 15266450
[TBL] [Abstract][Full Text] [Related]
12. Relationship between age and incidence of parkinsonism in psychiatric patients treated with haloperidol.
Moleman P; Janzen G; von Bargen BA; Kappers EJ; Pepplinkhuizen L; Schmitz PI
Am J Psychiatry; 1986 Feb; 143(2):232-4. PubMed ID: 3946663
[TBL] [Abstract][Full Text] [Related]
13. Tentative clinical profile of bromperidol.
Bobon DP
Acta Psychiatr Belg; 1978; 78(1):190-6. PubMed ID: 347881
[No Abstract] [Full Text] [Related]
14. Bromperidol decanoate (depot) for schizophrenia.
Purgato M; Adams CE
Cochrane Database Syst Rev; 2011 Sep; (9):CD001719. PubMed ID: 21901678
[TBL] [Abstract][Full Text] [Related]
15. Bromperidol maintenance in schizophrenia.
McEvoy JP; Wilson WH; Ban TA; Brannen JO; Berney S
Pharmacopsychiatria; 1982 May; 15(3):95-6. PubMed ID: 7100263
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of effectiveness and tolerance of the long-term treatment with bromoperidol decanoate in psychotic disorders].
Levi Minzi A; Laviani M
Minerva Psichiatr; 1992; 33(1):51-5. PubMed ID: 1406161
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial with bromperidol in psychotic states.
Brasseur R
Acta Psychiatr Belg; 1978; 78(1):110-7. PubMed ID: 645404
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of bromperidol and perphenazine.
Woggon B; Angst J
Int Pharmacopsychiatry; 1978; 13(3):165-76. PubMed ID: 355182
[TBL] [Abstract][Full Text] [Related]
19. [Treatment with bromperidol in schizophrenic patients].
Ellerman LA
Acta Psiquiatr Psicol Am Lat; 1988 Dec; 34(4):335-40. PubMed ID: 2908218
[TBL] [Abstract][Full Text] [Related]
20. [Introductory words to the exchange of results on the clinical effects of bromperidol. Results of open and double blind research].
Bures E; Pöldinger W
Int Pharmacopsychiatry; 1978; 13 Suppl 1():45-52. PubMed ID: 35479
[No Abstract] [Full Text] [Related]
[Next] [New Search]